Interaction Guide · Research summary

Can I take Calcium with Hydrochlorothiazide?

Review Calcium with Hydrochlorothiazide: possible adverse effects and timing and monitoring, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Large or prolonged calcium supplement use with hydrochlorothiazide can increase the risk of high blood calcium. The sources support reviewing the calcium product and dose and considering calcium monitoring, rather than a blanket rule to avoid all calcium.

What this answer covers

Applies to oral hydrochlorothiazide; risk depends on calcium and vitamin D intake, kidney function and conditions affecting calcium regulation.

Supplement or preparation
Calcium
Medication ingredient
hydrochlorothiazide

Evidence and practical considerations

Side effects & toxicity

Exact hydrochlorothiazide labeling and/or human evidence supports the candidate with the stated route, duration, and risk boundaries.

Exact scope
calcium supplements with hydrochlorothiazide
Medication form and route
oral
Timing or duration
Risk rises with large or prolonged calcium exposure; no universal timing interval was established.

What remains uncertain

  • Risk is conditional on dose, co-supplementation, renal function, and underlying calcium-metabolism disorders; no universal avoidance rule is supported.

Factors that may matter: calcium dose; vitamin D co-use; renal function; baseline calcium; hyperparathyroidism; older age.

Research conclusion: supported with conditions · Evidence assessment: moderate

Read the supporting source summaries

Source 1: major academic medical center clinical guidance

mayoclinic.org · Source check Jul 24, 2026

Population: People taking antihypertensive medicines including hydrochlorothiazide.

Mayo states large calcium amounts with thiazides including hydrochlorothiazide can raise milk-alkali risk and advises review of calcium type, dose, timing, and calcium levels.

Clinical guidance does not quantify risk by calcium dose or patient subgroup.

Source 2: United States prescribing information

accessdata.fda.gov · Source check Jul 24, 2026

Population: Patients receiving oral hydrochlorothiazide for hypertension or edema.

The label states that thiazides reduce urinary calcium excretion, can slightly raise serum calcium, and that marked hypercalcemia may reveal hyperparathyroidism.

The label summarizes known risks and management but does not provide a modern incidence estimate for every endpoint.

Research assessment: · Open full citations ↗

Timing & monitoring

Exact hydrochlorothiazide labeling and/or human evidence supports the candidate with the stated route, duration, and risk boundaries.

Exact scope
calcium supplements with hydrochlorothiazide
Medication form and route
oral
Timing or duration
Disclosure is ongoing; limitation or calcium monitoring depends on dose and susceptibility.

What remains uncertain

  • Risk is conditional on dose, co-supplementation, renal function, and underlying calcium-metabolism disorders; no universal avoidance rule is supported.

Factors that may matter: calcium dose; vitamin D co-use; renal function; baseline calcium; hyperparathyroidism.

Research conclusion: supported with conditions · Evidence assessment: moderate

Read the supporting source summaries

Source 1: major academic medical center clinical guidance

mayoclinic.org · Source check Jul 24, 2026

Population: People taking antihypertensive medicines including hydrochlorothiazide.

Mayo states large calcium amounts with thiazides including hydrochlorothiazide can raise milk-alkali risk and advises review of calcium type, dose, timing, and calcium levels.

Clinical guidance does not quantify risk by calcium dose or patient subgroup.

Source 2: United States prescribing information

accessdata.fda.gov · Source check Jul 24, 2026

Population: Patients receiving oral hydrochlorothiazide for hypertension or edema.

The label states that thiazides reduce urinary calcium excretion, can slightly raise serum calcium, and that marked hypercalcemia may reveal hyperparathyroidism.

The label summarizes known risks and management but does not provide a modern incidence estimate for every endpoint.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Research summary published

Article revision: 91b6f3d69967b094

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.